TipRanks
Advertisement
Advertisement

DE:DPM Stock Latest News

Sumitomo Pharma to Book Extraordinary Income From Retirement Benefit Trust Asset Return
Company AnnouncementsSumitomo Pharma to Book Extraordinary Income From Retirement Benefit Trust Asset Return
1M ago
Sumitomo Pharma Rejects Short-Seller Report, Defends AMCHEPRY Approval
PremiumCompany Announcements
Sumitomo Pharma Rejects Short-Seller Report, Defends AMCHEPRY Approval
2M ago
Sumitomo Pharma Rebuts Short-Seller Report, Defends Accounting Practices
PremiumCompany Announcements
Sumitomo Pharma Rebuts Short-Seller Report, Defends Accounting Practices
2M ago
Sumitomo Pharma Rejects Allegations in Gotham City Research Report
PremiumCompany Announcements
Sumitomo Pharma Rejects Allegations in Gotham City Research Report
2M ago
Sumitomo Pharma Q1 FY2026 Profit Surges Despite Higher Costs
PremiumCompany Announcements
Sumitomo Pharma Q1 FY2026 Profit Surges Despite Higher Costs
2M ago
Sumitomo Pharma Flags Uncertainty in Q1 FY2026 Outlook
PremiumCompany AnnouncementsSumitomo Pharma Flags Uncertainty in Q1 FY2026 Outlook
2M ago
Sumitomo Pharma Affirms Independence as Sumitomo Chemical Retains Control
Premium
Company Announcements
Sumitomo Pharma Affirms Independence as Sumitomo Chemical Retains Control
3M ago
Sumitomo Pharma Cancels Planned Third-Party Share Allotment After Allottee Declines
Premium
Company Announcements
Sumitomo Pharma Cancels Planned Third-Party Share Allotment After Allottee Declines
4M ago
Is DNPUF a Buy, Before Earnings?
PremiumPre-Earnings
Is DNPUF a Buy, Before Earnings?
4M ago
Sumitomo Pharma Profit Surges on Higher Revenue and Cost Controls
PremiumCompany Announcements
Sumitomo Pharma Profit Surges on Higher Revenue and Cost Controls
5M ago
Sumitomo Pharma Issues Cautious FY2025 Results Conference Materials
PremiumCompany Announcements
Sumitomo Pharma Issues Cautious FY2025 Results Conference Materials
5M ago
Sumitomo Pharma Ends Major Equity Offering, Withdraws Share Issuance Shelf
PremiumCompany Announcements
Sumitomo Pharma Ends Major Equity Offering, Withdraws Share Issuance Shelf
5M ago
Sumitomo Pharma Sets Terms for Over ¥100 Billion Equity Offering
PremiumCompany AnnouncementsSumitomo Pharma Sets Terms for Over ¥100 Billion Equity Offering
5M ago
Sumitomo Pharma Refinances Guaranteed Debt With New Bridge Loan
Premium
Company Announcements
Sumitomo Pharma Refinances Guaranteed Debt With New Bridge Loan
6M ago
Sumitomo Pharma Launches Major Share Offering to Strengthen Financial Base
Premium
Company Announcements
Sumitomo Pharma Launches Major Share Offering to Strengthen Financial Base
6M ago
Sumitomo Pharma to Book ¥48.3 Billion Dividend as Non-Operating Income With No Group Profit Impact
PremiumCompany Announcements
Sumitomo Pharma to Book ¥48.3 Billion Dividend as Non-Operating Income With No Group Profit Impact
6M ago
Sumitomo Pharma Wins Conditional Japan Approval for First iPS Cell-Derived Parkinson’s Therapy
PremiumCompany Announcements
Sumitomo Pharma Wins Conditional Japan Approval for First iPS Cell-Derived Parkinson’s Therapy
7M ago
Sumitomo Pharma Launches ‘Boost 2028’ Plan to Build on V-Shaped Recovery
PremiumCompany Announcements
Sumitomo Pharma Launches ‘Boost 2028’ Plan to Build on V-Shaped Recovery
7M ago
Sumitomo Pharma Lifts Full-Year Profit Outlook on Strong GEMTESA Sales and Weaker Yen
PremiumCompany Announcements
Sumitomo Pharma Lifts Full-Year Profit Outlook on Strong GEMTESA Sales and Weaker Yen
7M ago
Sumitomo Pharma Files ¥140 Billion Shelf Registration to Fund Growth and Bolster Finances
PremiumCompany AnnouncementsSumitomo Pharma Files ¥140 Billion Shelf Registration to Fund Growth and Bolster Finances
7M ago
Sumitomo Pharma’s iPS Cell Parkinson’s Therapy Heads to Key Japan Regulatory Review
Premium
Company Announcements
Sumitomo Pharma’s iPS Cell Parkinson’s Therapy Heads to Key Japan Regulatory Review
8M ago
Sumitomo Pharma Posts Surging Profit and Higher Revenue in Q3 FY2025 Under IFRS
Premium
Company Announcements
Sumitomo Pharma Posts Surging Profit and Higher Revenue in Q3 FY2025 Under IFRS
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >